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The phosphomimetic mutation S82D in the cancer-associated, FAD-
dependent human NADP(H):quinone oxidoreductase 1 (hNQO1) causes a
decrease in flavin-adenine dinucleotide-binding affinity and intracellular stabil-
ity. We test in this work whether the evolutionarily recent neutral mutation
R80H in the vicinity of S82 may alter the strong functional effects of S82
phosphorylation through electrostatic interactions. We show using biophysical
and bioinformatic analyses that the reverse mutation H80R prevents the
effects of S82D phosphorylation on hNQO1 by modulating the local stability.
Consistently, in rat NQO1 (rNQO1) which contains R80, the effects of phos-
phorylation were milder, resembling the behaviour found in hNQO1 when this
residue was humanized in rNQO1 (by the R80H mutation). Thus, apparently
neutral and evolutionarily divergent mutations may determine the functional
response of mammalian orthologues towards phosphorylation.
Keywords: epistasis; flavoprotein; molecular evolution; protein
phosphorylation
There are about 100 human proteins that depend on
flavin nucleotides [mostly flavin-adenine dinucleotide
(FAD) and flavin-mononucleotide (FMN)] for their
catalytic function [1]. Most catalyse oxidoreduction
reactions involved in metabolic processes, in which the
flavin cofactor plays a critical role [1]. Flavin binding
also controls flavoprotein intracellular stability by
modulating the levels of degradation-prone flavin-free
species (i.e. the apostate) [2-5]. Whether flavin binding
simply leads to global thermodynamic stabilization of
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the native state or increases the local stability of initia-
tion sites for degradation is still a matter of debate
[2,6,7,8]. Nearly 2/3 of human flavoproteins are associ-
ated with genetic diseases due to single amino acid
exchanges (i.e. caused by missense mutations)
[1,6,8,9,10]. In addition, it is likely that flavin-binding
affinity (and consequently in vivo stability of flavopro-
teins) can be modulated by post-translational modifica-
tions such as phosphorylation, although our
knowledge on this matter is very limited [3]. In this
regard, we have recently reported that site-specific
pseudophosphorylation at position S82 of the human
NQO1 flavoenzyme [NADP(H):quinone oxidoreduc-
tase 1; EC 1.6.5.2; human NADP(H):quinone oxidore-
ductase 1 (hNQO1)] has dramatic effects on FAD-
binding affinity and reduces intracellular protein levels.
Human NADP(H):quinone oxidoreductase 1
(hNQO1) is a multifunctional stress protein involved in
both enzymatic and nonenzymatic functions, including
the detoxification of quinones, activation of cancer pro-
drugs, stabilization of transcription factors such as p53
and p73α upon direct physical interaction with them, and
in other regulatory protein:protein and protein:RNA
interactions (E. T. Salido, D. J. Timson, I. Betancor-
Fernández, R. Palomino-Morales, & A. L. Pey, under
review) [11-15]. Altered hNQO1 expression and activity
are associated with different pathologies, including can-
cer and several neurological disorders (e.g. Parkinson´s
and Alzheimer´s diseases) [2,8,12,15,16,17,18]. The
enzyme forms functional homodimers, with two domains
per monomer: an N-terminal domain (NTD, residues 1–
224), that contains most of the binding site for FAD and
the monomer:monomer interface, and a C-terminal
domain (CTD; residues 225–274) which is involved in
dimer stabilization and completes the binding sites for
NADH and the substrates [12,19,20,21,22,23]. FAD
binding is essential for the catalytic activity of hNQO1,
acting as two-electron donor and acceptor during the cat-
alytic cycle [8,24]. In addition, the high affinity for FAD
[with a dissociation constant (Kd) in the 10–20 nM range]
[25-27] and the adequate supply of riboflavin as precursor
of FAD contribute to maintain the levels of the
degradation-prone, highly flexible and partially unfolded
apoprotein at low levels, thus controlling hNQO1 intra-
cellular degradation rates [2,4,28]. Accordingly, the single
amino acid exchange P187S and phosphorylation at the
S82 site reduce 10- to 40-fold FAD-binding affinity with
a concomitant effect on hNQO1 steady-state levels intra-
cellularly [2,19,20,25]. Phosphorylation at position S82 is
highly conserved across mammalian NQO1 sequences, as
well as at the adjacent residues in the sequence, with a
few exceptions (particularly residue 80; Fig. 1A). This
phosphorylation event has been reported in 14 different
analyses of the flavoproteome (https://www.phosphosite.
org/proteinAction.action?id=14721&showAllSites=true).
The phosphomimetic mutation S82D destabilizes this
region (particularly the region comprising residues 50–
90) both in the holo- and apo-states of hNQO1, and this
effect propagates to the FAD-binding site severely
reducing its affinity for the flavin [3]. Importantly, this
region contains a network of highly conserved ionizable
residues that are likely responsible for the effects of
S82D on FAD binding (Fig. 1B,C). Among these
charged residues, the most noticeable exception is H80
in the human sequence vs the consensus sequence
(Fig. 1C). The consensus amino acid at this position is
R80 (Fig. 1C) engages in favourable interactions with
neighbouring charged residues [27]. Consequently, the
mutation H80R stabilizes this region in hNQO1, and
the presence of R80 in most mammalian sequences (for
instance, rat NQO1) may cause a similar effect.
Although the H80R mutation has nearly neutral effects
on hNQO1 (for instance on its binding affinity for
FAD), it is capable of overcoming the effect of P187S
on FAD-binding affinity through epistatic effects
[26,27,29]. Therefore, we hypothesize that the mutations
H80R and S82D may cause their opposing effects on
FAD-binding affinity through charge–charge interac-
tions acting on the same electrostatic network in the
NTD. In this context, we propose that: (a) the presence
of the H80R in hNQO1 would overcome the effects
caused by the phosphomimetic mutation S82D on
FAD-binding affinity; (b) since R80 is present in most
of mammalian NQO1 sequences, although the phospho-
rylation of S82 may occur in these proteins, their effects
would be modulated by the presence of R80 in close
proximity. To test these proposals, we carried out struc-
tural and functional comparative analyses on hNQO1
and rat NQO1 (rNQO1). Our results supported that,
due to the evolutionary divergence at residue 80, the
phenotypic manifestation of phosphorylating S82
largely diverges between these highly similar
orthologues.
Materials and methods
Protein expression and purification from
Escherichia coli
Site-directed mutagenesis to introduce the S82D mutation
was carried out on the pET-46 Ek/LIC containing hNQO1
H80R sequence as described earlier [25,27] and using the
QuikChange lightening kit (Agilent Technologies, Madrid,
Spain). Mutagenesis was confirmed by sequencing the
entire cDNA. The cDNA of rNQO1 was synthesized and
subcloned into the pET-15b vector by GenScript (Leiden,
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The Netherlands) and used as template to generate by site-
directed mutagenesis in rNQO1 the mutants R80H, S82D
and R80H-S82D. Expression in and purification of wild-
type (WT) and mutants from Escherichia coli BL21 (DE3),
as well as preparation of apoproteins (using a KBr/urea-
based procedure), were carried out as previously described
[3]. Purified proteins were exchanged to 50 mM HEPES (2-
[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid)-KOH
at pH 7.4 and stored at −80 °C upon flash-freezing in liq-
uid N2. Along this manuscript, we refer to apoproteins
[ligand-free NQO1 (NQO1apo)] for those NQO1 samples in
which FAD was stripped and holoproteins [FAD-bound
NQO1 (NQO1holo)] for those in which proteins were incu-
bated with a large excess of FAD (typically 100 μM).
Titrations with FAD
Flavin-adenine dinucleotide-binding studies were carried
out by fluorescence titrations of NQO1apo with FAD as
described in Ref. [30]. Both hNQO1apo and rNQO1apo pro-
teins (at a 0.25 μM concentration) were titrated in 20 mM
potassium phosphate at pH 7.4 (or in 50 mM HEPES-
KOH, see Table S1) at 25 °C for at least 10 min. Fluores-
cence emission spectra were recorded in the 340–360 nm
Fig. 1. Sequence conservation and structural features in the proximity of the H80 and S82 sites. (A) Sequence alignment of the region
comprising residues 61–100 in hNQO1 and those of mammalian orthologous proteins. Residues in bold and underlined indicate nonidentical
sites vs hNQO1. (B) Structural location of H80 and S82 in the hNQO1 structure regarding the FAD cofactor is shown as black spheres (PDB
code: 1D4A) [22]. Ionizable residues that can interact with H80/R80 and/or S82/D82 residues and affect FAD binding are indicated in grey. (C)
Frequency of sequence conservation of ionizable residues shown in panel B from the alignment of mammalian sequences displayed in panel
(A). The consensus sequence is indicated as large letters and frequency indicated as the size of the letter. Figure reproduced from Ref. [22].
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range (excitation at 280 nm) using 5 nm slits, at a
200 nmmin−1 scan rate and averaged over 10 consecutive
scans. Plots of intensity at 350 nm vs total FAD concentra-
tion were used to obtain Kd (Kd values) upon fitting by
using a single site binding model [27]. Experiments were
replicated at least twice for each variant.
Proteolysis
Kinetic proteolysis studies by thermolysin were performed
in 50 mM HEPES-KOH, 10 mM CaCl2 at pH 7.4 and
25 °C, as recently described [27,28]. hNQO1apo protein
variants were used at 10–20 μM concentration, with an
excess of 100 μM FAD, and experiments were carried out
using a concentration of 0.01–0.8 μM in thermolysin. Prote-
olysis was initiated by addition of the protease, and sam-
ples were withdrawn at different times and quenched by
adding a final concentration of 25 mM EDTA at pH 8.
Samples were denatured with Laemmli´s buffer and anal-
ysed by polyacrylamide gel electrophoresis in the presence
of SDS (SDS/PAGE) containing 12% acrylamide. Gels
were scanned and analysed using the IMAGEJ software
(https://imagej.nih.gov/). Time-dependent decay of
uncleaved NQO1 was used to determine first-order rate
constants (kobs) from fittings carried out using an exponen-
tial function. Second-order rate constants (kprot) were
obtained by dividing first-order rate constants by the pro-
tease concentration used.
Double-mutant cycles
Thermodynamic double-mutant cycles were built using data
from proteolysis kinetics (kprot) and FAD-binding affinities
(Kd). These cycles allowed us to determine thermodynamic
effects of mutations from variations in relevant free energies
(ΔΔG) for proteolysis or FAD binding between protein vari-
ants. For proteolysis kinetics, ΔΔGprotðABÞ ¼ R  T  ln kprotðBÞkprotðAÞ
where kprot(i) values were the corresponding second-order
proteolysis rate constants, R was the ideal gas constant
(1.987 calmol−1K−1), and T was the experimental absolute
temperature. Since the kprot was determined under condi-
tions at which the proteolytic step was rate-limiting [28,31],
and both A and B species (e.g. WT vs a mutant) were




equal to the ratio of the equilibrium constant between
cleavable (X) and native states (N) for the A and B species
(e.g. WT and a mutant). A positive value of ΔΔGprot(A − B)
indicates that A has higher stability than B (i.e. A has a
lower equilibrium constant; K ¼ ½X½N the population of X is
lower for A than for B). For FAD binding,
ΔΔGbindingðABÞ ¼ R  T  ln KdðBÞKdðAÞ where Kd is the dissociation
constant for FAD binding for species A and B, respec-
tively. A positive value of ΔΔGbinding(A − B) indicates that
the state A binds FAD more tightly than B (i.e. A has
lower Kd than B). Errors associated with ΔΔG were deter-
mined by propagation of fitting errors.
Hydrogen/deuterium exchange mass
spectrometry
Amide hydrogen/deuterium exchange (HDX) of NQO1 was
investigated for hNQO1 variants in the NQO1apo and
NQO1holo forms essentially as described in Ref. [32]. Briefly,
the exchange reaction was initiated by a 10-fold dilution of
20 μM protein with a D2O-based buffer containing 50 mM
HEPES-KOH, pD 7.4, 0.5 mM tris(2-carboxyethyl)
phosphine. The exchange was terminated at different points
as described in Ref. [32]. Custom-made columns coupled in
tandem were used for proteolysis that was done at 0 °C by
0.4% formic acid in water [32]. The generated peptides were
desalted on a SecurityGuard™ precolumn (ULTRA Car-
tridges UHPLC Fully Porous Polar C18, 2.1 mm, Phenom-
enex, Torrance, CA, USA) using the same solvent and flow
that were used for digestion. Solvent was delivered by using
a 1260 Infinity II Quaternary pump (Agilent Technologies,
Waldbronn, Germany). Peptides were further separated on
an analytical column (LUNA® Omega Polar C18 Column,
100 Å, 1.6 µm, 100 mm × 1.0 mm; Phenomenex) by linear
gradient (10–40% buffer B in 6 min; buffer B contained
0.1% FA/98% ACN in water) followed by a quick step to
99% B lasting 5 min. Solvent delivery on the analytical col-
umn was managed as described in Ref. [32] Digestion,
desalting and separation were performed at 0 °C and pH 2.3
to minimize deuterium back-exchange. The outlet of the col-
umn was online connected to an ESI source of 15T FT-ICR
mass spectrometer (Bruker Daltonics, Bremen, Germany)
operating in broad-band positive ion MS mode. Data were
exported using DATAANALYSIS 5.0 (Bruker Daltonics) and
processed by in-house developed program Deutex (unpub-
lished). Peptide identification was done in a separate data-
dependent LC-MS/MS run. Data were exported to mgf files
using DATAANALYSIS 5.0 and searched against database con-
taining sequences of NQO1 variants, proteases used in the
experiment and common contaminating proteins (cRAP
database). As a semiquantitatively measurement of the HDX
kinetic differences between hNQO1 variants and/or ligation
states, we used Δ%Dav that is calculated from the three
most different values in HDX kinetics between a given state
and the reference state [32]
Molecular dynamics simulations
Molecular dynamics (MD) of dimeric hNQO1 was per-
formed by using the GROMACS package [33], largely following
a protocol previously applied [3]. Eight simulation runs were
carried out, differing by the absence or presence of (a) the
FAD cofactor (apo- and holostates, respectively); (b) the
suppressor mutation H80R; and (c) the phosphomimetic
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mutation S82D. The protein structures were built starting
from the crystallographic structure of the holoprotein (PDB
entry 1D4A [22]). The addition of a few missing atoms and
residue modifications at the mutation sites were carried out
in silico by using visual MD (VMD) [34].
The protein was solvated in a rhombic dodecahedron box
with a minimum distance of 1 nm from each wall, resulting
in ~ 17 800 water molecules, and Cl− counterions were
added to obtain an overall neutral system charge. Classical
MD was performed with periodic boundary conditions in
the isothermal-isobaric ensemble, using the AMBER force
field 99SB-ILDN for the protein [35], the generalized
AMBER force field (GAFF) for FAD [36], and the TIP3P
model for water [37]. Other conditions, including reference
values and coupling times for the thermostat and barostat,
modelling of nonbonded Coulomb and van der Waals inter-
actions, and distance constraints on bonds, were as previ-
ously described [38,39]. Each simulation run was carried out
with a sampling time of 1 ps, for a total time of 100 ns.
The structural and dynamic properties of hNQO1 were
assessed by calculating atomic deviations and fluctuations
in the protein structure, after rototranslation with a least
squares fit to the Cα atoms with respect to the starting con-
formation to account for protein diffusion. Equilibration of
protein inner motion was assessed by monitoring the root
mean square deviations (RMSDs) of Cα atoms; 10 ns was
typically sufficient for the NQO1holo, and further analysis
was carried out in the 20- to 100-ns time interval for ensur-
ing a complete equilibration in all the cases. For all simula-
tions, values for RMSDs and for root mean square
fluctuations (RMSFs) were calculated as averages on both
protein monomers, and the two outmost residues at the N
and C termini of the protein chains were excluded in the
analysis due to their high mobility.
Electrostatic calculations were carried out using the
solvent-accessibility corrected Tanford–Kirkwood model
[40] as recently described [27] taking as input the average
structures from the last 80 ns of the MD simulations. The
output of these analyses provided the energy of charge–
charge interactions of a given ionizable residue with all the
individual ionizable amino acids in the protein dimer (Eq–q)
and was averaged for each ionizable residue.
Results and Discussion
The mutation H80R protects hNQO1 against the
effects of S82D on FAD binding without affecting
interaction with SAMp73
To prove whether H80R may protect hNQO1 towards
the most deleterious effect known for the phospho-
mimetic mutation S82D (i.e. the affinity for FAD) [3],
we produced and purified hNQO1 WT, the single
mutants H80R and S82D and the double-mutant
H80R-S82D, and characterized their affinity for FAD.
It is worth noting that the introduction of these muta-
tions on hNQO1 did not affect the overall dimeric
structure of hNQO1holo and hNQO1apo states (Figs S1
and S2). Titrations of hNQO1 variants were carried
out in phosphate buffer to obtain accurate measure-
ments for high-affinity variants (according to Ref. [26])
and provide results also consistent with those in
HEPES buffer (Table S1) [3,27]. Under these condi-
tions, we observed a mild increase in affinity for FAD
in H80R whereas the S82D mutant showed a decrease
in FAD-binding affinity by 11-fold (Fig. 2A). Impor-
tantly, the interaction between H80R and S82D basi-
cally restored the affinity for FAD to that of hNQO1
WT (Fig. 2A).
To support that the interaction between H80R and
S82D overcomes the local destabilization of the phos-
phomimetic mutation in the vicinity of the FAD-
binding site (residues 50–90) [3,27], we carried out com-
parative analysis of the resistance of NQO1holo proteins
against proteolytic cleavage by thermolysin. The initial
cleavage by thermolysin occurs in hNQO1holo WT (as
well as in the H80R, S82D and H80R-S82D mutants;
see Fig. S3) between S72 and V73 (named the ther-
molysin cleavage site; TCS) leading to the accumula-
tion of a cleavage intermediate of ~ 22.8 kDa (see
Fig. S3) [28]. The TCS is half-way between the
mutated sites in H80R and S82D and the FAD mole-
cule (with shortest distances of 6.4, 7.5 and 10 Å,
respectively; Fig. 2B) and thus allows to correlate the
changes in the local stability due to these mutations
and their propagation to the FAD-binding site [3,27].
Proteolysis experiments were carried out under condi-
tions in which the proteolysis rate constants depended
linearly on protease concentration, and thus, the
second-order proteolysis rate constants (kprot) reported
the effect of mutations on the thermodynamic local
stability of the TCS (Fig. S2B–D) [41,42].
The mutations H80R and S82D had clear effects on
the local stability of the TCS, causing a five-fold
decrease and a 30-fold increase in kprot, respectively.
This indicates an important stabilization for H80R
and destabilization for S82D around this region (Fig. 2
B). Remarkably, the interaction between these two
mutations in the H80R-S82D mutant essentially
restored the local stability of the TCS to that observed
in the WT protein (Fig. 2B). These results thus sup-
port that the mutation R80H that occurred about
20 Myr ago [27] might have made hNQO1 more sensi-
tive to the phosphorylation effects at S82.
The quantitative analyses reported here for the effects
of the mutations H80R and S82D on hNQO1, and
their interaction, allowed us to build double-mutant
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cycles to evaluate their effects on FAD-binding affinity
and local stability of the TCS (Fig. 2C,D). The first
point to note is the existence of epistasis between these
two mutations (i.e. the effect of a given mutation
depends on the presence or absence of the other muta-
tion) (Fig. 2C,D). It is evident that the H80R mutation
shows stronger effects in the presence of the S82D
mutation, whereas the effect of the S82D mutation is
much milder in the presence of the H80R mutation
(Fig. 2C,D). Additionally, the double-mutant cycles
revealed similar effects on FAD-binding affinity and the
stability of the TCS, although some quantitative differ-
ences beyond the experimental uncertainty were
observed. This can be easily rationalized because FAD-
binding affinity should depend on the effects of muta-
tions on the conformational landscape of hNQO1holo
and hNQO1apo (i.e. the FAD-binding site). In contrast,
proteolysis kinetics by thermolysin only reports on the
effects on hNQO1holo (note that proteolysis on
hNQO1apo does not unambiguously reports on the sta-
bility of the TCS) [28]. We also compared the average
change in TCS stability and FAD binding, going from
WT to the H80R-S82D using both pathways (either
S82D or H80R as intermediate) with the actual ΔΔG
change observed between H80R-S82D and the WT pro-
tein. In both cases, the double mutants show virtually
the same ΔΔG values (diagonal arrows in the cycles;
Fig. 2).
A critical function of hNQO1 is its interaction with
protein partners (such as p73α) that depends to some
extent to the catalytic competence of the protein (E. T.
Salido, D. J. Timson, I. Betancor-Fernández, R.
Palomino-Morales, & A. L. Pey, under review)
[19,27,43]. Previous studies have shown that the single
mutations H80R and S82D lead to certain differences in
the interaction of hNQO1 with SAMp73α, as observed
by NMR spectroscopy experiments [3,19,27]. However,
the mutant H80R-S82D showed little perturbation of
Fig. 2. Effects of the mutations S82D and H80R on the affinity for the FAD as hNQO1apo proteins and local stability of the NTD as
hNQO1holo proteins from proteolysis kinetics. (A) Titrations of hNQO1apo variants with FAD. Fluorescence intensity was normalized using
that of the apoprotein in the absence of FAD. Data are from 2 to 3 independent titrations. Kd values were determined by using a single type
of independent binding site model. Protein concentration was 0.25 μM. (B) Proteolysis kinetics by thermolysin. The upper panel shows the
location of the H80 and S82 residues regarding the TCS and the FAD molecule (PDB code: 2F1O) [46]. The table shows the second-order
proteolysis rate constants (kprot) for hNQO1holo variants. (C, D) Double-mutant cycles for FAD-binding affinity (C) and proteolysis (D, for
NQO1holo variants). The diagonal arrows indicate the approximate change in ΔG from WT and double mutant as initial and final states. All
experiments were performed at 25 °C. Figure reproduced from Ref. [46].
6 FEBS Letters (2021) ª 2021 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies
Phosphorylation effects on human and rat NQO1 J. L. Pacheco-Garcia et al.
the set of residues in SAMp73α upon interaction with
hNQO1 (Fig. S4).
High-resolution structural characterization of the
interaction between H80R and S82D in hNQO1
To determine at high resolution the mechanism by which
the interaction of the mutation H80R with S82D leads to
structural stabilization of the FAD-binding site, we first
determined the effects of these single mutations and their
combination on the local stability of hNQO1holo and
hNQO1apo by hydrogen–deuterium exchange monitored
by mass spectrometry (HDXMS) [32] (Fig. 3). Since
HDX occurs under the EX2 regime (in which the intrinsic
exchange rate constant kint is much lower than the rate
constant kcl for the conversion between nonexchanging
and exchanging states, according to the Linderstrøm-
Lang model) [44], changes due to ligand binding and/or
mutations report changes in local thermodynamic stabil-
ity for the different protein segments [32]. It must be
noted that the kinetic behaviour under HDX conditions
is very complex and heterogeneous for the hNQO1 pro-
tein, and thus, a direct analysis of ligand binding and
mutational effects on local stability from HDX kinetics is
not straightforward (see [32] for a detailed Discussion;
Figs S5–S8). Therefore, to compare the effects of the
H80R and S82D mutations on the local stability of
hNQO1holo and hNQO1apo, we determined Δ%Dav val-
ues for different segments (Figs S5–S8), as a simple met-
ric that describes semiquantitatively changes in HDX
kinetics [32]. Please note that a positive value of Δ%Dav
indicates destabilization vs. the reference state, while a
negative value indicates stabilization (Fig. 3).
In the hNQO1holo state, the mutation S82D caused
significant structural destabilization of the NTD in the
regions involving residues 50–90 and 100–120, and this
effect is particularly strong in the segments 69–74 and
110–113 (in agreement with a recent report) [30],
whereas the mutation H80R strongly stabilizes the seg-
ment 50–90 (Fig. 3A and Fig. S5). Remarkably, for
the double-mutant H80R-S82D, the effects of the sin-
gle mutations on the segments 50–90 essentially cancel
out (Fig. 3A and Fig. S5). Analogous analyses of the
hNQO1apo state reveal a similar, but more complex,
scenario (also in agreement with a recent report) [30].
The mutation S82D destabilizes segments 50–90 and
100–140, although to a lower extent than for the
hNQO1holo state. The mutation H80R stabilizes the
segments 50–90 to a similar extent than that observed
for the NQO1holo state, and this stabilization is also
observed in segments 50–90 and 100–120. The double-
mutant H80R-S82D showed a behaviour half-way
between of those of H80R and S82D (Fig. 3A and Fig.
S5). Interestingly, the mutations H80R and S82D also
cause some mild long-range effects on the stability of
the CTD in the NQO1apo state (Fig. 3A and Fig. S5).
Since the regions in the NTD whose stabilities are
affected by the mutations S82D and H80R are in the
vicinity of the FAD-binding site, these effects on struc-
tural stability might translate into changes in the FAD-
binding affinity. This correlation is evident when we
compare the effect of these two mutations on the struc-
tural stability of the FAD-binding site (i.e. those residues
in direct contact with the flavin cofactor in the crystal
structure; [32]). Interestingly, we found that the mutation
S82D significantly reduces the stability of the FAD-
binding site, both in the NQO1holo and NQO1apo states,
whereas the effects of the mutation H80R are marginal
(Fig. 3B). The interaction between the mutations H80R
and S82D on the double mutant essentially abolished
the deleterious effects of S82D on the FAD-binding site
(Fig. 3B). Importantly, the effects of the single mutations
and their combination in the double mutant seem to be
stronger on hNQO1holo, thus explaining the good corre-
lation found in the double-mutant cycles.
It is likely that alterations in electrostatic interactions
in the NTD caused by the mutations H80R and S82D
are largely responsible for the functional rescue in the
double mutant through structural stabilization of the
FAD-binding site and its surroundings. However, we
might expect that the presence of R80 and D82 in the
double mutant alters the local electrostatic environment
beyond their simple binary electrostatic interaction (see
Fig. 1A). For instance, our HDXMS studies together
with previous structural data indicate that the mutation
H80R may alter the electrostatic interactions of this res-
idue with certain neighbouring residues, particularly
K59, E71 and E78, and consequently the local stability
[27,29]. As we pointed out earlier, most of the residues
involved on this electrostatic network are well con-
served among mammalian sequences, the main excep-
tion being H80 (Fig. 1B,C). To further characterize
these effects in the local electrostatic network, we calcu-
lated changes in electrostatic energies upon introduction
of the H80R and/or S82D mutations on the averaged
structures provided by MD simulations. These changes
mostly localized around the mutated residues in the
MD simulations (i.e. they were local) and mostly
involved ionizable residues in the region comprising res-
idues 50–90 (Fig. 4A and Fig. S9). Introduction of the
single mutations H80R and S82D on the hNQO1holo
and hNQO1apo states had opposing effects, leading to
favourable and unfavourable electrostatic interactions
with neighbouring residues, respectively (Fig. 4A).
When both the H80R and S82D were present, we
observed some (but not full) compensation of their
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effects on electrostatic interactions in both ligation
states. These analyses agreed well with those derived
from HDXMS studies (Fig. 4B).
Additionally, the single mutations H80R and S82D
also led to modest changes in the conformation and
dynamics in the vicinity of the FAD-binding site (Fig.
Fig. 3. Effects of the mutations H80R and S82D on the structural stability of hNQO1 as determined by HDXMS. The figure shows a
structural representation of the effect of S82D and H80R and its combination in the hNQO1 protein as holo- and apoprotein. Residues
depicted in the orange (destabilizing) and green (stabilizing) indicate those whose stability differs from the WT protein (as determined by
Δ%Dav values). Panel (A) shows these stability effects for the hNQO1 dimer, whereas panel (B) shows a close-view of those residues that
form the FAD-binding site according to Ref. [32]. Figure reproduced from Ref. [32].
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Fig. 4. An evolutionarily conserved electrostatic network mediates the effect of mutations H80R and S82D on the stability of the NTD. (A)
Changes in electrostatic interactions derived from MD simulations. The colour maps showed the changes in electrostatic energy using the
WT structure as reference (ΔEq–q) for the ionizable residues in the N-terminal half of NQO1 (for the results showing the full length protein,
see Fig. S9). Changes larger than 0.25 kcalmol−1 in the vicinity of the FAD molecule were mapped onto the structure of the S82D, H80R
and H80R-S82D variants. Bar plots in the right side showed the total effect of the residues highlighted in the structures. Colour scales
indicated the ΔEq–q for colour maps and structural displays. Positive values indicate destabilizing and negative values stabilizing effects,
respectively. (B) HDXMS analysis shows that this network of electrostatic interactions mostly involving residues 45–90 in the NTD leads to
changes in local stability. Δ%Dav refer to changes in stability vs hNQO1 WT.
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S10). The effects on the conformation were more
noticeable for hNQO1apo than for hNQO1holo, and
remarkably important near the loops 58–67, previously
shown to be key for explaining the effects of the muta-
tions H80R and S82D on FAD binding [3,29]
(Fig. S10A–C,E,F). In the double mutant, we observed
that the effect of the mutations on the conformation
of the FAD-binding site largely (but not fully) can-
celled out in hNQO1apo (Fig. S10D–G). This would
contribute to explain the compensatory effect of the
H80R mutation on the S82D mutation regarding FAD
binding to hNQO1. The mutation H80R also reduced
the dynamics in the vicinity of the FAD-binding site in
hNQO1apo, which may reflect stabilization of FAD-
binding competent states, whereas the S82D mutation
caused much milder effects (Fig. S10E,F). Again, these
effects on dynamics largely cancelled out in the
hNQO1apo in the double mutant, thus suggesting that
this cancellation of effects could contribute to their
compensatory behaviour on FAD-binding affinity.
Overall, these analyses combining HDXMS and MD
simulations supported that electrostatic interactions
modulate the local stability, conformation and dynam-
ics in the vicinity of the FAD-binding site, and these
effects are key to explain the opposing effects of S82D
and H80R on the binding affinity of NQO1 for the fla-
vin cofactor and their compensation in the double-
mutant H80R-S82D.
Rat NQO1 is resistant to the effects of S82D due
to the mutation R80
We would expect that mammalian orthologues con-
taining R80 would be less sensitive to the phospho-
mimetic mutation S82D. To test this hypothesis, we
purified rat NQO1 (rNQO1) that contains R80 (see
Fig. 1C) as well as rNQO1 containing the mutation
S82D, and two humanized versions in which the muta-
tion R80H was introduced with or without the muta-
tion S82D, and determined their affinity for FAD
(Fig. 5). The mutation S82D had much weaker effect
on rNQO1 (two-fold decrease in affinity) than in
hNQO1 (11-fold decrease in affinity). The humanizing
mutation R80H in rNQO1 reduced the affinity for
Fig. 5. Effects of the S82D and R80H
mutations on the affinity for the FAD of
rNQO1apo proteins. (A) Titrations of apo-
rNQO1 variants with FAD. Fluorescence
intensity was normalized by using the
intensity of the apoprotein in the absence
of FAD. Data are from two independent
titrations. Kd values were determined by
fittings using a single type of independent
binding sites. Protein concentration was
0.25 μM. (B) Double-mutant cycles for
FAD-binding affinity. The diagonal arrows
indicate the approximate change in ΔG
from WT and double mutant as initial and
final states. Experiments were performed
at 25 °C.
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FAD to a value close to that of hNQO1. More impor-
tantly, when the humanizing mutation R80H was com-
bined with the mutation S82D, we observed a 30-fold
decrease in affinity vs WT rNQO1. Overall, these
results strongly support that the mutation R80H that
occurred about 20 Myr ago [27] has rendered NQO1
from some primates (including humans) sensitive to
phosphorylation at position S82. This might represent
a recent evolutionary change in the functional response
of NQO1 due to phosphorylation, mainly due to the
mutation R80H that occurred 20 Myr ago. Again, we
compared the value of ΔΔG from two ways (Fig. 5).
These results strongly support that our mutant cycles
work well from the initial to the final state.
Conclusions
Along molecular evolution, proteins develop new func-
tions and regulatory mechanisms through mutations
[45]. We have previously shown that phosphorylation
of hNQO1 at the residue S82 had large effects in FAD
binding and intracellular stability [3], whereas the evo-
lutionary divergent mutation R80H (that occurred
during primate speciation about 20 Myr ago) is almost
neutral for WT hNQO1 [27]. In this work, we showed
that the interaction of S82D with H80R or the inverse
mutation in hNQO1 and rNQO1 may have turned off/
on evolutionarily shifted with a recently occurred sin-
gle mutation. Our results showed that rNQO1 is not
sensitive to phosphorylation at residue S82, but the
single and humanizing mutation R80H makes rNQO1
sensitive to phosphorylation at this site. Overall, our
results allow us to hypothesize that a single
evolutionary-related mutation may switch on/off the
effects of phosphorylation in protein function in many
other proteins.
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ALP thanks Professors José Manuel Sánchez-Ruiz and
Beatriz Ibarra-Molero (both from the University of
Granada) for providing access and advice on their
home-built software for electrostatic calculations. BR
acknowledges kind hospitality and use of computa-
tional resources in the European Magnetic Resonance
Center (CERM), Sesto Fiorentino (Florence), Italy.
This work was supported by Spanish Ministry of
Economy and Competitiveness and European ERDF
Funds (MCIU/AEI/FEDER, EU) [RTI2018-097991-B-
I00 to JLN and RTI2018-096246-B-I00 to ALP];
FEDER/Junta de Andalucia-Consejerı́a de Transfor-
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